JP7690265B2 - Chinese herbal medicine - Google Patents
Chinese herbal medicine Download PDFInfo
- Publication number
- JP7690265B2 JP7690265B2 JP2020110245A JP2020110245A JP7690265B2 JP 7690265 B2 JP7690265 B2 JP 7690265B2 JP 2020110245 A JP2020110245 A JP 2020110245A JP 2020110245 A JP2020110245 A JP 2020110245A JP 7690265 B2 JP7690265 B2 JP 7690265B2
- Authority
- JP
- Japan
- Prior art keywords
- weight
- extract
- parts
- seishinrenshi
- glycyrrhizinic acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
Description
本発明は、清心蓮子飲エキスを含有する漢方製剤に関する。 The present invention relates to a herbal medicine containing Seishinrenshi-in extract.
清心蓮子飲エキスは、9種の生薬を含む生薬混合物の抽出エキスであり、全身倦怠感があり、口や舌が乾き、尿が出しぶるものの次の諸症:残尿感、頻尿、排尿痛に用いられる(非特許文献1、2)。 Seishinrenshi-in extract is an extract of a mixture of herbs containing nine kinds of herbs, and is used for the following symptoms in people with general fatigue, dry mouth and tongue, and heavy urination: residual urine, frequent urination, and painful urination (Non-Patent Documents 1, 2).
清心蓮子飲エキスの製造方法としては、生薬混合物を、水を用いて煎出(非特許文献1、2)する方法が一般的である。 The most common method for producing Seishinrenshi-in extract is to decoct a mixture of herbs using water (Non-Patent Documents 1 and 2).
清心蓮子飲エキスの製造に用いられるカンゾウに含まれるグリチルリチン酸には抗炎症作用、免疫調節作用、肝細胞増殖作用をはじめとする多くの薬効の薬理作用が報告されている(非特許文献3)。また、グリチルリチン酸は砂糖の約170倍もの甘味を有することが知られている(非特許文献4)。 Glycyrrhizic acid, which is contained in licorice used in the production of Seishinrenshi-in extract, has been reported to have many pharmacological effects, including anti-inflammatory, immunomodulatory, and hepatocyte proliferation effects (Non-Patent Document 3). Glycyrrhizic acid is also known to be about 170 times sweeter than sugar (Non-Patent Document 4).
清心蓮子飲エキス中に含まれるカンゾウ由来のグリチルリチン酸が多くなれば、当該成分による薬理作用をより効果的に享受することができると考えられる。工業的に通常用いられている製造方法でも、甘草に含まれていた成分含量等によってはグリチルレチン酸の含量が多い清心蓮子飲エキスが得られることもある。しかしながら、本発明者が検討したところ、清心蓮子飲エキス中のグリチルリチン酸が0.22重量%以上になると、当該成分による甘味が強すぎて、清心蓮子飲エキス製剤は特有の不快な甘味を呈する。 It is believed that the more glycyrrhizinic acid derived from licorice contained in Seishinrenshi-in extract, the more effectively the pharmacological effects of this ingredient can be enjoyed. Even with the manufacturing methods normally used industrially, it is possible to obtain Seishinrenshi-in extract with a high content of glycyrrhizinic acid, depending on the content of ingredients contained in the licorice. However, the inventor's investigations have shown that when the glycyrrhizinic acid content in Seishinrenshi-in extract is 0.22% by weight or more, the sweetness of this ingredient is too strong, and Seishinrenshi-in extract preparations exhibit a peculiar, unpleasant sweetness.
そこで、本発明は、グリチルリチン酸を0.22重量%以上含有する清心蓮子飲エキスを含有する漢方製剤において、グリチルリチン酸の特有の不快な甘味を抑制する処方を提供することを目的とする。 The present invention aims to provide a formulation that suppresses the unpleasant sweetness characteristic of glycyrrhizinic acid in a herbal medicine containing Seishinrenshi-in extract, which contains 0.22% by weight or more of glycyrrhizinic acid.
本発明者らは、独自の製造方法によって、清心蓮子飲エキスに含まれる様々な成分の比率を変化させたところ、グリチルリチン酸100重量部に対して、オノニンの含有量が8重量部以上となるように調整することによって、グリチルリチン酸の特有の不快な甘味が抑制されることを見出した。本発明は、この知見に基づいて、更に検討を重ねることにより完成したものである。 The inventors have used their own manufacturing method to vary the ratios of various components contained in Seishinrenshiin extract, and have found that by adjusting the content of ononin to 8 parts by weight or more per 100 parts by weight of glycyrrhizinic acid, the unpleasant sweetness characteristic of glycyrrhizinic acid can be suppressed. The present invention was completed based on this finding and through further investigation.
即ち、本発明は、下記に掲げる態様の発明を提供する。
項1. 清心蓮子飲エキスを含有する漢方製剤であって、
前記清心蓮子飲エキス中、グリチルリチン酸の含有量が0.22重量%以上、且つグリチルリチン酸100重量部に対するオノニンの含有量が8重量部以上である、漢方製剤。
項2. 散剤、細粒剤、顆粒剤、トローチ剤、又はチュアブル剤である、項1に記載の漢方製剤。
項3. グリチルリチン酸を0.22重量%以上含有する清心蓮子飲エキスを含有する漢方製剤においてグリチルリチン酸の甘味を抑制する方法であって、
前記清心蓮子飲エキス中、グリチルリチン酸100重量部に対しオノニンの含有量が8重量部以上となるように調整する、方法。
That is, the present invention provides the following aspects.
Item 1. A herbal medicine containing Seishinrenshiin extract,
The Chinese herbal medicine, wherein the seishinrenshi-in extract contains 0.22% by weight or more of glycyrrhizic acid and contains 8 parts by weight or more of ononin per 100 parts by weight of glycyrrhizic acid.
Item 2. The herbal preparation according to Item 1, which is in the form of a powder, fine granules, granules, lozenges, or chewable preparation.
Item 3. A method for suppressing the sweetness of glycyrrhizinic acid in a herbal medicine containing Seishinrenshi-in extract containing 0.22% by weight or more of glycyrrhizinic acid, comprising:
The method comprises adjusting the content of ononin in the Seishinrenshi-in extract to 8 parts by weight or more per 100 parts by weight of glycyrrhizinic acid.
本発明によれば、グリチルリチン酸を0.22重量%以上含有する清心蓮子飲エキスを含有する漢方製剤において、グリチルリチン酸の特有の不快な甘味を抑制することが可能となる。 According to the present invention, it is possible to suppress the unpleasant sweetness characteristic of glycyrrhizinic acid in a herbal medicine preparation containing Seishinrenshi-in extract, which contains 0.22% by weight or more of glycyrrhizinic acid.
1.漢方製剤
本発明の漢方製剤は、特定成分が特定比率で含まれる清心蓮子飲エキスを含有することを特徴とする。以下、本発明の漢方製剤について詳述する。
The herbal preparation of the present invention is characterized by containing a seishinrenshiin extract containing specific ingredients in specific ratios. The herbal preparation of the present invention will be described in detail below.
清心蓮子飲は、中国明時代の医書「万病回春」に記載されており、レンニク、バクモンドウ、ブクリョウ、ニンジン、シャゼンシ、オウゴン、オウギ、ジコッピ、カンゾウを含む混合生薬である。 Seishinrenshiin is described in the Chinese Ming Dynasty medical book Banbyo Kaishun, and is a mixture of herbs containing lotus root, Chinese radish, bupleurum, ginseng, Chinese scutellaria, Scutellaria baicalensis, Astragalus chinensis, jikoppi, and licorice.
本発明において、清心蓮子飲を構成する生薬の混合比については特に制限されないが、通常、レンニク2~5重量部、好ましくは3~4重量部;バクモンドウ1.5~4重量部、好ましくは2~3重量部;ブクリョウ2~4重量部、好ましくは2.5~3.5重量部;ニンジン1.5~5重量部、好ましくは2~4重量部;シャゼンシ1.5~3重量部、好ましくは2~2.5重量部;オウゴン1.5~3重量部、好ましくは2~2.5重量部;オウギ1~4重量部、好ましくは2~3重量部;ジコッピ1~3重量部、好ましくは2~2.5重量部;カンゾウ0.7~2重量部、好ましくは0.7~1重量部が挙げられる。 In the present invention, there is no particular restriction on the mixing ratio of the herbs that make up Seishinrenshi-in, but typically includes 2-5 parts by weight of Lotus Root, preferably 3-4 parts by weight; 1.5-4 parts by weight of Bakumondou, preferably 2-3 parts by weight; 2-4 parts by weight of Poria Root, preferably 2.5-3.5 parts by weight; 1.5-5 parts by weight of Ginseng, preferably 2-4 parts by weight; 1.5-3 parts by weight of Shazenshi, preferably 2-2.5 parts by weight; 1.5-3 parts by weight of Scutellaria Root, preferably 2-2.5 parts by weight; 1-4 parts by weight of Astragalus Root, preferably 2-3 parts by weight; 1-3 parts by weight of Jikoppi, preferably 2-2.5 parts by weight; and 0.7-2 parts by weight of Licorice, preferably 0.7-1 part by weight.
本発明で使用される清心蓮子飲エキスの製造に供される生薬調合物の好適な例としては、レンニク3.5重量部、バクモンドウ2.1重量部、ブクリョウ2.8重量部、ニンジン3.5重量部、シャゼンシ2.1重量部、オウゴン2.1重量部、オウギ2.8重量部、ジコッピ2.1重量部、カンゾウ0.7重量部が挙げられる。 Suitable examples of herbal medicine preparations used in the manufacture of the Seishinrenshiin extract used in the present invention include 3.5 parts by weight of Lotus Root, 2.1 parts by weight of Bakumondou, 2.8 parts by weight of Poria Coccinea, 3.5 parts by weight of Ginseng, 2.1 parts by weight of Shazenshi, 2.1 parts by weight of Scutellaria Root, 2.8 parts by weight of Astragalus Root, 2.1 parts by weight of Jikoppi, and 0.7 parts by weight of Licorice.
本発明に用いられる清心蓮子飲エキスは、グリチルリチン酸が0.22重量%以上含まれる。このようにグリチルリチン酸の含量が高い清心蓮子飲エキスを含む漢方製剤は、特有の不快な甘味を呈するが、本発明の漢方製剤では、グリチルリチン酸が高含量でありながら、特有の不快な甘味が抑制されている。 The Seishinrenshi-in extract used in the present invention contains 0.22% by weight or more of glycyrrhizinic acid. Thus, herbal preparations containing Seishinrenshi-in extracts with a high content of glycyrrhizinic acid have a characteristic unpleasant sweetness, but the herbal preparation of the present invention has a high content of glycyrrhizinic acid, yet the characteristic unpleasant sweetness is suppressed.
本発明の漢方製剤は、特有の不快な甘味の抑制効果に優れているため、グリチルリチン酸の含量がより一層高い場合であっても、効果的に不快な甘味を抑制することができる。このような観点から、本発明に用いられる清心蓮子飲エキスに含まれるグリチルリチン酸の好適な例としては、0.3重量%以上、より好ましくは0.4重量%以上、さらに好ましくは0.45重量%以上、一層好ましくは0.48重量%以上が挙げられる。本発明に用いられる清心蓮子飲エキスに含まれるグリチルリチン酸の上限としては特に限定されないが、例えば1重量%以下、好ましくは0.9重量%以下が挙げられる。 The herbal preparation of the present invention has an excellent effect of suppressing the specific unpleasant sweetness, and therefore can effectively suppress the unpleasant sweetness even when the content of glycyrrhizinic acid is much higher. From this viewpoint, suitable examples of the glycyrrhizinic acid contained in the Seishinrenshi-in extract used in the present invention include 0.3% by weight or more, more preferably 0.4% by weight or more, even more preferably 0.45% by weight or more, and even more preferably 0.48% by weight or more. There is no particular limit to the upper limit of the glycyrrhizinic acid contained in the Seishinrenshi-in extract used in the present invention, but examples include 1% by weight or less, preferably 0.9% by weight or less.
また、本発明に用いられる清心蓮子飲エキスは、グリチルリチン酸100重量部に対し、オノニンの含有量を8重量部以上含む。これによって、高含量のグリチルリチン酸に特有の不快な甘味が抑制される。不快な甘味の抑制効果をより一層高める観点から、グリチルリチン酸100重量部に対するオノニンの含有量の好ましい例としては、8.3重量部以上又は9重量部以上、より好ましくは11重量部以上、さらに好ましくは13重量部以上、一層好ましくは15重量部以上、特に好ましくは16重量部以上が挙げられる。グリチルリチン酸100重量部に対するオノニンの含有量の上限としては特に限定されないが、例えば23重量部以下、好ましくは19重量部以下が挙げられる。 The Seishinrenshi-in extract used in the present invention contains 8 parts by weight or more of ononin per 100 parts by weight of glycyrrhizinic acid. This suppresses the unpleasant sweetness that is specific to high contents of glycyrrhizinic acid. From the viewpoint of further enhancing the effect of suppressing the unpleasant sweetness, preferred examples of the ononin content per 100 parts by weight of glycyrrhizinic acid include 8.3 parts by weight or more or 9 parts by weight or more, more preferably 11 parts by weight or more, even more preferably 13 parts by weight or more, even more preferably 15 parts by weight or more, and particularly preferably 16 parts by weight or more. There is no particular limit to the upper limit of the ononin content per 100 parts by weight of glycyrrhizinic acid, but examples include 23 parts by weight or less, preferably 19 parts by weight or less.
本発明に用いられる清心蓮子飲エキス中のオノニンの含有量としては、グリチルリチン酸100重量部に対する量が上述の量である限りにおいて特に限定されないが、例えば、0.02重量%以上、好ましくは0.028重量%以上、より好ましくは0.05重量%以上、さらに好ましくは0.07重量%以上、特に好ましくは0.08重量%以上が挙げられる。本発明に用いられる清心蓮子飲エキスに含まれるオノニン含有量の上限としては特に限定されないが、例えば0.4重量%以下、好ましくは0.2重量%以下が挙げられる。 The content of ononin in the Seishinrenshiin extract used in the present invention is not particularly limited as long as the amount relative to 100 parts by weight of glycyrrhizinic acid is the amount described above, but examples include 0.02% by weight or more, preferably 0.028% by weight or more, more preferably 0.05% by weight or more, even more preferably 0.07% by weight or more, and particularly preferably 0.08% by weight or more. The upper limit of the ononin content contained in the Seishinrenshiin extract used in the present invention is not particularly limited, but examples include 0.4% by weight or less, preferably 0.2% by weight or less.
本発明に用いられる清心蓮子飲エキスに含まれるグリチルリチン酸は、その少なくとも一部が清心蓮子飲を構成するカンゾウに由来しているが、好ましくは、その全てが清心蓮子飲を構成するカンゾウに由来している。 At least a portion of the glycyrrhizic acid contained in the Seishinrenshiin extract used in the present invention is derived from the licorice that constitutes Seishinrenshiin, but preferably all of it is derived from the licorice that constitutes Seishinrenshiin.
本発明に用いられる清心蓮子飲エキスに含まれるオノニンは、その少なくとも一部が清心蓮子飲を構成するオウギに由来しているが、好ましくは、その全てが清心蓮子飲を構成するオウギに由来している。 At least a portion of the ononin contained in the seishinrenshiin extract used in the present invention is derived from the Astragalus radix that constitutes seishinrenshiin, but preferably all of it is derived from the Astragalus radix that constitutes seishinrenshiin.
清心蓮子飲エキス中のグリチルリチン酸の含量及びそれに対するオノニンの含有比率を上記の範囲に調整する方法の一例として、清心蓮子飲エキスを調整した後、不足しているグリチルリチン酸及び/又はオノニンを添加する方法が挙げられる。この方法において、グリチルリチン酸及び/又はオノニンの添加に使用される成分としては、それら精製化合物であってもよいし、カゾウエキス、オウギエキス、又はカンゾウ及びオウギの混合生薬のエキスであってもよい。 One example of a method for adjusting the content of glycyrrhizinic acid and the ratio of ononin to glycyrrhizinic acid in Seishinrenshi-in extract to fall within the above range is to add the missing glycyrrhizinic acid and/or ononin after adjusting Seishinrenshi-in extract. In this method, the components used to add glycyrrhizinic acid and/or ononin may be purified compounds thereof, or may be an extract of liquorice root extract, Astragalus membranaceus extract, or a mixed herbal extract of licorice root and Astragalus membranaceus.
不快な甘味の抑制効果をより一層高める観点から、清心蓮子飲エキス中のグリチルリチン酸の含量及びそれに対するオノニンの含有比率を上記の範囲に調整する方法の他の例として、清心蓮子飲を構成する生薬混合物に用いるオウギ、又はカンゾウ及びオウギの細切物の少なくとも一部に、公称目開き1mmの篩を通過する大きさに砕いた細かい細切物を用いる方法が好ましい。この方法において、清心蓮子飲を構成する生薬混合物に用いるオウギ、又はカンゾウ及びオウギの細切物の一部に、前記の細かい細切物を用いる場合(つまり、当該細切物の一部が前記の細かい細切物であり、残りが公称目開き4mmの篩を通過しない大きさに砕いた通常の大きさの細切物である場合)、カンゾウの全細切物1重量部に対するカンゾウの前記の細かい細切物の比率、オウギの全細切物1重量部に対するオウギの前記の細かい細切物の比率、としてはいずれも、0.3重量部以上が挙げられる。不快な甘味の抑制効果をより一層高める観点から、当該比率はいずれも、好ましくは0.5重量部以上、より好ましくは0.7重量部以上、さらに好ましくは0.9重量部以上が挙げられる。不快な甘味の抑制効果を更に高める観点から、清心蓮子飲を構成する生薬混合物に用いるオウギ、又はカンゾウ及びオウギの細切物が全て前記の細かい細切物であることが最も好ましい。 As another example of a method for adjusting the content of glycyrrhizinic acid and the content ratio of ononin in Seishinrenshi-in extract to the above range from the viewpoint of further enhancing the effect of suppressing unpleasant sweetness, a method is preferred in which finely chopped pieces crushed to a size that passes through a sieve with a nominal mesh size of 1 mm are used as at least a part of the Astragalus Root or the finely chopped pieces of licorice and Astragalus Root used in the herbal mixture constituting Seishinrenshi-in. In this method, when the finely chopped pieces are used as part of the Astragalus Root or the finely chopped pieces of licorice and Astragalus Root used in the herbal mixture constituting Seishinrenshi-in (i.e., when a part of the finely chopped pieces is the finely chopped pieces and the rest is normal-sized finely chopped pieces crushed to a size that does not pass through a sieve with a nominal mesh size of 4 mm), the ratio of the finely chopped pieces of licorice to 1 part by weight of the total finely chopped pieces of licorice and the ratio of the finely chopped pieces of Astragalus Root to 1 part by weight of the total finely chopped pieces of Astragalus Root are both 0.3 parts by weight or more. From the viewpoint of further enhancing the effect of suppressing unpleasant sweetness, the ratio is preferably 0.5 parts by weight or more, more preferably 0.7 parts by weight or more, and even more preferably 0.9 parts by weight or more. From the viewpoint of further enhancing the effect of suppressing unpleasant sweetness, it is most preferable that all of the finely chopped Astragalus Root or the finely chopped Licorice and Astragalus Root used in the herbal mixture constituting Seishinrenshi-in are the above-mentioned finely chopped products.
清心蓮子飲のエキスは、上記の混合生薬を抽出処理し、得られた抽出液を必要に応じて濃縮又はさらに乾燥させることにより得ることができる。 The extract of Seishinrenshiin can be obtained by subjecting the above-mentioned mixed herbal medicines to an extraction process, and concentrating or further drying the resulting extract as necessary.
清心蓮子飲エキスの抽出処理に使用される抽出溶媒としては、特に限定されず、水又は含水エタノール、好ましくは水が挙げられる。また、清心蓮子飲の液状のエキスは、得られた抽出液を濃縮することにより得ることができる。さらに、清心蓮子飲の乾燥エキス末は、液状のエキスを乾燥処理することにより得ることができる。乾燥処理の方法としては特に限定されず、例えば、スプレードライ法や、エキスの濃度を高めた軟エキスに適当な吸着剤(例えば無水ケイ酸、デンプン等)を加えて吸着末とする方法等が挙げられる。 The extraction solvent used in the extraction process of Seishinrenshiin extract is not particularly limited, and may be water or aqueous ethanol, preferably water. The liquid extract of Seishinrenshiin can be obtained by concentrating the obtained extract. Furthermore, the dried extract powder of Seishinrenshiin can be obtained by drying the liquid extract. The method of drying is not particularly limited, and may be, for example, spray drying or a method in which a suitable adsorbent (e.g., silicic anhydride, starch, etc.) is added to a soft extract with a high extract concentration to obtain an adsorbed powder.
清心蓮子飲のエキスの形態としては、流エキス、軟エキス等の液状のエキス、又は固形状の乾燥エキス末のいずれであってもよい。 The extract form of Seishinrenshiin can be either a liquid extract such as a liquid extract or a soft extract, or a solid dried extract powder.
本発明の漢方製剤中の清心蓮子飲エキスの含有量としては、本発明の効果を奏する限り、特に限定されないが、清心蓮子飲エキスの乾燥エキス末量換算で、10~100重量%、好ましくは20~90重量%、より好ましくは40~80重量%、更に好ましくは60~70重量%が挙げられる。なお、本発明において、清心蓮子飲の乾燥エキス末量換算とは、清心蓮子飲の乾燥エキス末を使用する場合にはそれ自体の量であり清心蓮子飲の液状のエキスを使用する場合には、溶媒を除去した残量に換算した量である。また、清心蓮子飲の乾燥エキス末が、製造時に添加される吸着剤等の添加剤を含む場合は、当該添加剤を除いた量である。 The content of Seishinrenshiin extract in the herbal preparation of the present invention is not particularly limited as long as the effects of the present invention are achieved, but may be 10 to 100% by weight, preferably 20 to 90% by weight, more preferably 40 to 80% by weight, and even more preferably 60 to 70% by weight, calculated as the amount of dried extract powder of Seishinrenshiin extract. In the present invention, the amount of dried extract powder of Seishinrenshiin refers to the amount of the dried extract powder itself when a dried extract powder of Seishinrenshiin is used, and refers to the amount converted to the amount remaining after removing the solvent when a liquid extract of Seishinrenshiin is used. In addition, when the dried extract powder of Seishinrenshiin contains additives such as adsorbents added during production, the amount refers to the amount excluding the additives.
その他の成分
本発明の漢方製剤は、清心蓮子飲エキス単独からなるものであってもよく、製剤形態に応じた添加剤や基剤を含んでいてもよい。このような添加剤及び基剤としては、薬学的に許容されることを限度として特に制限されないが、例えば、賦形剤、結合剤、崩壊剤、滑沢剤、等張化剤、可塑剤、分散剤、乳化剤、溶解補助剤、湿潤化剤、安定化剤、懸濁化剤、粘着剤、コーティング剤、光沢化剤、水、油脂類、ロウ類、炭化水素類、脂肪酸類、高級アルコール類、エステル類、水溶性高分子、界面活性剤、金属石鹸、低級アルコール類、多価アルコール、pH調整剤、緩衝剤、酸化防止剤、紫外線防止剤、防腐剤、矯味剤、香料、粉体、増粘剤、色素、キレート剤等が挙げられる。これらの添加剤は、1種単独で使用してもよく、また2種以上を組み合わせて使用してもよい。また、これらの添加剤及び基剤の含有量については、使用する添加剤及び基剤の種類、漢方製剤の製剤形態等に応じて適宜設定される。
Other components The herbal preparation of the present invention may be composed of the seishinrenshiin extract alone, or may contain additives and bases according to the preparation form. Such additives and bases are not particularly limited as long as they are pharmacologic acceptable, and examples thereof include excipients, binders, disintegrants, lubricants, isotonicity agents, plasticizers, dispersants, emulsifiers, solubilizers, wetting agents, stabilizers, suspending agents, adhesives, coating agents, glossing agents, water, oils and fats, waxes, hydrocarbons, fatty acids, higher alcohols, esters, water-soluble polymers, surfactants, metal soaps, lower alcohols, polyhydric alcohols, pH adjusters, buffers, antioxidants, UV inhibitors, preservatives, flavorings, fragrances, powders, thickeners, dyes, chelating agents, etc. These additives may be used alone or in combination of two or more. The content of these additives and bases is appropriately set according to the type of additives and bases used, the preparation form of the herbal preparation, etc.
また、本発明の漢方製剤は、清心蓮子飲エキスの他に、必要に応じて、他の栄養成分や薬理成分を含有していてもよい。このような栄養成分や薬理成分としては、薬学的に許容されることを限度として特に制限されないが、例えば、制酸剤、健胃剤、消化剤、整腸剤、鎮痙剤、粘膜修復剤、抗炎症剤、収れん剤、鎮吐剤、鎮咳剤、去痰剤、消炎酵素剤、鎮静催眠剤、抗ヒスタミン剤、カフェイン類、強心利尿剤、抗菌剤、血管収縮剤、血管拡張剤、局所麻酔剤、生薬エキス、ビタミン類、メントール類等が挙げられる。これらの栄養成分や薬理成分は、1種単独で使用してもよく、また2種以上を組み合わせて使用してもよい。また、これらの成分の含有量については、使用する成分の種類等に応じて適宜設定される。 In addition, the herbal preparation of the present invention may contain other nutritional components and pharmacological components as necessary in addition to the Seishinrenshi-in extract. Such nutritional components and pharmacological components are not particularly limited as long as they are pharmacologic acceptable, but examples thereof include antacids, stomachic agents, digestive agents, intestinal regulators, antispasmodics, mucosal repair agents, anti-inflammatory agents, astringents, antiemetics, antitussives, expectorants, anti-inflammatory enzymes, sedatives, hypnotics, antihistamines, caffeine, cardiac diuretics, antibacterial agents, vasoconstrictors, vasodilators, local anesthetics, herbal extracts, vitamins, and menthols. These nutritional components and pharmacological components may be used alone or in combination of two or more. The content of these components is appropriately set depending on the type of components used.
製剤形態
本発明の漢方製剤の製剤形態については、経口投与が可能であることを限度として特に制限されないが、例えば、散剤、細粒剤、顆粒剤、錠剤(好ましくは素錠剤)、トローチ剤、チュアブル剤、カプセル剤(軟カプセル剤、硬カプセル剤)、丸剤等の固形状製剤;ゼリー剤等の半固形状製剤;液剤、懸濁剤、シロップ剤等の液状製剤が挙げられ、好ましくは、散剤、細粒剤、顆粒剤、トローチ剤、チュアブル剤が挙げられる。
Preparation form The preparation form of the herbal preparation of the present invention is not particularly limited, as long as it can be administered orally. Examples of the preparation form include solid preparations such as powders, fine granules, granules, tablets (preferably plain tablets), troches, chewable tablets, capsules (soft capsules, hard capsules), and pills; semi-solid preparations such as jellies; and liquid preparations such as solutions, suspensions, and syrups. Preferred are powders, fine granules, granules, troches, and chewable tablets.
製造方法
本発明の漢方製剤の製造方法は、上記の方法によって得た、特定成分が特定比率で含まれる清心蓮子飲エキスを用い、必要に応じて他の成分を用いて、医薬分野で採用されている通常の製剤化手法に従って製剤化すればよい。
Manufacturing method: The manufacturing method for the herbal preparation of the present invention is to use the Seishinrenshi-in extract obtained by the above-mentioned method, which contains specific ingredients in specific ratios, and to formulate it using other ingredients as necessary, according to conventional formulation methods used in the pharmaceutical field.
2.甘味を抑制する方法
上述するように、グリチルリチン酸が高含量である清心蓮子飲エキスにおいて、グリチルリチン酸に対して特定量のオノニンを含むように調整することで、高含量のグリチルリチン酸に特有の不快な甘味を抑制する効果を発現させる。従って、本発明は、更に、グリチルリチン酸を0.22重量%以上含有する清心蓮子飲エキスを含有する漢方製剤においてグリチルリチン酸の甘味を抑制する方法であって、前記清心蓮子飲エキス中、グリチルリチン酸100重量部に対しオノニンの含有量が8重量部以上となるように調整する方法を提供する。
2. Method for suppressing sweetness As described above, by adjusting the content of ononin in Seishinrenshi-in extract, which has a high content of glycyrrhizinic acid, to a specific amount relative to glycyrrhizinic acid, the effect of suppressing the unpleasant sweetness specific to high content of glycyrrhizinic acid is exhibited.Therefore, the present invention further provides a method for suppressing the sweetness of glycyrrhizinic acid in a herbal medicine containing Seishinrenshi-in extract containing 0.22% by weight or more of glycyrrhizinic acid, by adjusting the content of ononin in Seishinrenshi-in extract to 8 parts by weight or more relative to 100 parts by weight of glycyrrhizinic acid.
本発明の甘味を抑制する方法において、使用する清心蓮子飲エキスに含まれる成分の含有量や比率、当該含有量及び比率に調整するための方法、漢方製剤に配合される成分の種類や含有量、及び製剤形態等については、前記「1.漢方製剤」のに記載の通りである。 In the method of suppressing sweetness of the present invention, the contents and ratios of the ingredients contained in the Seishinrenshiin extract used, the method for adjusting said contents and ratios, the types and contents of the ingredients blended in the herbal preparation, and the formulation form are as described above in "1. Herbal Preparations."
以下、本発明を実施例により具体的に説明するが、本発明はこれらの実施例に限定されるものではない。 The present invention will be described in detail below with reference to examples, but the present invention is not limited to these examples.
(1)清心蓮子飲エキスの調製
原料生薬として、レンニク3.5重量部、バクモンドウ2.1重量部、ブクリョウ2.8重量部、ニンジン3.5重量部、シャゼンシ2.1重量部、オウゴン2.1重量部、オウギ2.8重量部、ジコッピ2.1重量部、カンゾウ0.7重量部を用いた。これらのうちカンゾウ及びオウギについては、通常の細切物(公称目開き4mmの篩を通過しない大きさの細切物)、細かい細切物(公称目開き1mmの篩を通過する大きさの細切物)、又は通常の細切物0.5重量部と細かい細切物0.5重量部との混合物を用いた。カンゾウ及びオウギの細切物の大きさは揃えた。他の生薬については、通常の細切物(公称目開き4mmの篩を通過しない大きさの細切物)を用いた。
(1) Preparation of Seishinrenshiin Extract As raw herbal medicines, 3.5 parts by weight of Lotus Root, 2.1 parts by weight of Bakumondou, 2.8 parts by weight of Poria Root, 3.5 parts by weight of Ginseng, 2.1 parts by weight of Shazenshi, 2.1 parts by weight of Scutellaria Root, 2.8 parts by weight of Astragalus Root, 2.1 parts by weight of Jicopsis Root, and 0.7 parts by weight of Licorice were used. Of these, for Licorice Root and Astragalus Root, normal shredded material (shredded material of a size that does not pass through a sieve with a nominal mesh size of 4 mm), fine shredded material (shredded material of a size that passes through a sieve with a nominal mesh size of 1 mm), or a mixture of 0.5 parts by weight of normal shredded material and 0.5 parts by weight of fine shredded material were used. The shredded material of Licorice Root and Astragalus Root was the same size. For other herbal medicines, normal shredded material (shredded material of a size that does not pass through a sieve with a nominal mesh size of 4 mm) was used.
これらの生薬の細切物を混合し、水10倍重量を用いて約100℃で1時間抽出し、遠心分離して抽出液を得た。抽出液を減圧下で濃縮してスプレードライヤーを用いて乾燥し、清心蓮子飲エキス末を得た。得られた清心蓮子飲エキス末は、原料生薬混合物21.7g当たり2238mgであった。なお、スプレードライヤーによる乾燥は、抽出液を回転数10000rpmのアトマイザーに落下させ、150℃の空気の熱風を供給して行った。 These finely chopped herbs were mixed and extracted with 10 times the weight of water at approximately 100°C for 1 hour, then centrifuged to obtain an extract. The extract was concentrated under reduced pressure and dried using a spray dryer to obtain Seishinrenshi-in extract powder. The Seishinrenshi-in extract powder obtained weighed 2238 mg per 21.7 g of raw herb mixture. Drying using a spray dryer was performed by dropping the extract into an atomizer rotating at 10,000 rpm and supplying hot air at 150°C.
(2)グリチルリチン酸及びオノニンの測定
得られた清心蓮子飲エキスに含まれるグリチルリチン酸及びオノニンの含有量を、以下の方法で測定した。以下において、希釈した試薬の希釈率に関する「(x→y)」との記載は、当該試薬x体積部を水でy体積部に希釈したことを意味する。
(2) Measurement of glycyrrhizinic acid and ononin The contents of glycyrrhizinic acid and ononin contained in the obtained Seishinrenshi-in extract were measured by the following method. In the following, the notation "(x→y)" regarding the dilution ratio of a diluted reagent means that x parts by volume of the reagent was diluted with y parts by volume of water.
<グリチルリチン酸の測定>
乾燥エキス約0.2gを精密に量り、酢酸エチル20mL及び水10mLを加えて10分間振り混ぜた。これを遠心分離し、上層を除いた後、酢酸エチル20mLを加えて同様に操作し、上層を除いた。得られた水層にメタノール10mLを加えて30分間振り混ぜた後、遠心分離し、上澄液を分取した。残留物に希釈したメタノール(1→2)20mLを加えて5分間振り混ぜた後、遠心分離し、上澄液を分取し、先の上澄液と合わせ、希釈したメタノール(1→2)を加えて正確に50mLとし、試料溶液とした。別にグリチルリチン酸標準品約10mgを精密に量り、希釈したメタノール(1→2)に溶かして正確に100mLとし、標準溶液とした。
<Measurement of glycyrrhizic acid>
About 0.2 g of the dried extract was precisely weighed, 20 mL of ethyl acetate and 10 mL of water were added, and the mixture was shaken for 10 minutes. This was centrifuged, the upper layer was removed, and then 20 mL of ethyl acetate was added and the same procedure was repeated to remove the upper layer. 10 mL of methanol was added to the resulting aqueous layer, and the mixture was shaken for 30 minutes, then centrifuged, and the supernatant was separated. 20 mL of diluted methanol (1 → 2) was added to the residue, and the mixture was shaken for 5 minutes, then centrifuged, and the supernatant was separated, combined with the previous supernatant, and diluted methanol (1 → 2) was added to make exactly 50 mL, which was used as the sample solution. Separately, about 10 mg of glycyrrhizic acid standard was precisely weighed, and dissolved in diluted methanol (1 → 2) to make exactly 100 mL, which was used as the standard solution.
試料溶液及び標準溶液10μLずつを正確にとり、次の条件で液体クロマトグラフィーにより試験を行い、それぞれの液のグリチルリチン酸の試料溶液のピーク面積AT及び標準溶液のピーク面積ASを測定した。 10 μL of each sample solution and standard solution were taken accurately and tested by liquid chromatography under the following conditions, and the peak area AT of the sample solution of glycyrrhizinic acid and the peak area AS of the standard solution of glycyrrhizinic acid were measured for each solution.
(液体クロマトグラフィー試験条件)
検出器:紫外吸光光度計(測定波長:254nm)
カラム:内径4.6mm、長さ15cmのステンレス管に5μmの液体クロマトグラフィー用オクタデシルシリル化シリカゲルを充填した。
カラム温度:40℃付近の一定温度
移動相:酢酸アンモニウム3.85gを水720mLに溶かし、酢酸(100)5mL及びアセトニトリル280mLを加えた。
流量:毎分1.0mL
(Liquid Chromatography Test Conditions)
Detector: ultraviolet spectrophotometer (measurement wavelength: 254 nm)
Column: A stainless steel tube having an inner diameter of 4.6 mm and a length of 15 cm was packed with 5 μm octadecylsilylated silica gel for liquid chromatography.
Column temperature: constant temperature around 40° C. Mobile phase: 3.85 g of ammonium acetate was dissolved in 720 mL of water, and 5 mL of acetic acid (100) and 280 mL of acetonitrile were added.
Flow rate: 1.0 mL per minute
得られたピーク面積AT及びASを用い、下記式に基づいて、秤取量あたりのグリチルリチン酸の量(mg)を導出した。 Using the obtained peak areas AT and AS, the amount of glycyrrhizinic acid (mg) per weighed amount was calculated based on the following formula:
<オノニンの測定>
乾燥エキス約0.5gを精密に量り、メタノール50mLを正確に加えて30分間振り混ぜた後、30分間超音波抽出した。この液をろ過し、ろ液を試料溶液とした。別途、オノニン標準品を精密に量り、メタノールを加えて溶かし正確に100mLとした。このメタノール溶液を超音波照射し、標準溶液とした。試料溶液及び標準溶液を10μLずつ正確にとり、次の条件で液体クロマトグラフィーによる試験を行い、それぞれの試料溶液中のオノニンの試料溶液のピーク面積AT及び標準溶液のピーク面積ASを測定した。
<Measurement of Ononin>
Approximately 0.5 g of the dry extract was precisely weighed, 50 mL of methanol was accurately added, and the mixture was shaken for 30 minutes, followed by ultrasonic extraction for 30 minutes. This liquid was filtered, and the filtrate was used as the sample solution. Separately, ononin standard was precisely weighed, and methanol was added to dissolve it to make exactly 100 mL. This methanol solution was irradiated with ultrasonic waves to make the standard solution. 10 μL of each of the sample solution and standard solution were precisely taken, and tested by liquid chromatography under the following conditions, and the peak area AT of the sample solution and the peak area AS of the standard solution of ononin in each sample solution were measured.
(液体クロマトグラフィー試験条件)
検出器:紫外吸光光度計(測定波長:249nm)
カラム:内径4.6mm、長さ15cmのステンレス管に5μmの液体クロマトグラフィー用オクタデシルシリル化シリカゲルを充填した。
カラム温度:40℃付近の一定温度
移動相:希釈した酢酸(1→500)/アセトニトリル(4/1(体積比))混液
流量:毎分1.0mL
(Liquid Chromatography Test Conditions)
Detector: ultraviolet spectrophotometer (measurement wavelength: 249 nm)
Column: A stainless steel tube having an inner diameter of 4.6 mm and a length of 15 cm was packed with 5 μm octadecylsilylated silica gel for liquid chromatography.
Column temperature: constant temperature around 40°C Mobile phase: diluted acetic acid (1 → 500) / acetonitrile (4 / 1 (volume ratio)) mixture Flow rate: 1.0 mL per minute
得られたピーク面積AT及びASを用い、下記式に基づいて、オノニンの量を導出した。 The amount of ononin was calculated using the obtained peak areas AT and AS based on the following formula.
(3)甘味スコアの判定
呈味に関するトレーニングがされたモニター10名が、得られた清心蓮子飲エキス1gを直接舌の上に載せ、感じる甘味を、5段階(1が弱い、5が強い)でVAS評価し、モニター全員の評点を平均した。得られた平均点を以下の基準で分類し、甘味スコアを得た。結果を表1に示す。
(3) Evaluation of sweetness score Ten taste-trained monitors placed 1 g of the obtained Seishinrenshi-in extract directly on their tongues and evaluated the sweetness they felt on a 5-point scale (1 being weak, 5 being strong) using a VAS, and the scores of all the monitors were averaged. The obtained average scores were classified according to the following criteria to obtain a sweetness score. The results are shown in Table 1.
<甘味スコア>
+++++:4.7以上
++++:3.7以上4.7未満
+++:2.7以上3.7未満
++:1.7以上2.7未満
+:1.7未満
<Sweetness score>
++++++: 4.7 or more ++++: 3.7 or more and less than 4.7
+++: 2.7 or more and less than 3.7
++: 1.7 or more and less than 2.7
+: Less than 1.7
表1に示す通り、通常の細切物を用いて調製すると、グリチルリチン酸が0.18重量%、0.23重量%を含む清心蓮子飲エキス(参考例1、比較例1)が得られたが、グリチルリチン酸が0.23重量%を含む清心蓮子飲エキス(比較例1)では、極めて強い甘味を呈した。モニターによると、この極めて強い甘味は、グリチルリチン酸に特有の不快な甘味であった。 As shown in Table 1, when prepared using normal shredded material, Seishinrenshi-in extracts containing 0.18% and 0.23% by weight of glycyrrhizinic acid (Reference Example 1, Comparative Example 1) were obtained, but Seishinrenshi-in extract containing 0.23% by weight of glycyrrhizinic acid (Comparative Example 1) had an extremely strong sweetness. According to monitors, this extremely strong sweetness was the unpleasant sweetness unique to glycyrrhizinic acid.
一方、カンゾウ及びオウギの細切物の半分重量を、細かい細切物に置換して調製すると、グリチルリチン酸が増加するとともに、グリチルリチン酸に対するオノニンの比率が増加した清心蓮子飲エキス(実施例1、2)が得られた。そして、これらの清心蓮子飲エキス(実施例1、2)では、不快な強い甘味の原因となるグリチルリチン酸の含有量が多いにも関わらず、甘味は顕著に低減された。 On the other hand, when half the weight of the shredded licorice and astragalus root was replaced with finely shredded pieces, Seishinrenshi-in extracts (Examples 1 and 2) were obtained in which glycyrrhizinic acid was increased and the ratio of ononin to glycyrrhizinic acid was increased. Furthermore, in these Seishinrenshi-in extracts (Examples 1 and 2), despite the high content of glycyrrhizinic acid, which causes an unpleasant strong sweetness, the sweetness was significantly reduced.
さらに、カンゾウ及びオウギの細切物として全て細かい細切物を用いて調製すると、グリチルリチン酸が更に増加するとともに、グリチルリチン酸に対するオノニンの比率も更に増加した清心蓮子飲エキス(実施例3)が得られた。そして、この清心蓮子飲エキス(実施例3)では、不快な強い甘味の原因となるグリチルリチン酸の含有量がさらに多いにも関わらず、甘味はより一層顕著に低減された。 Furthermore, when the licorice and astragalus root were all finely chopped, a Seishinrenshi-in extract (Example 3) was obtained in which the amount of glycyrrhizinic acid was further increased and the ratio of ononin to glycyrrhizinic acid was also further increased. And, in this Seishinrenshi-in extract (Example 3), the sweetness was further significantly reduced, despite the fact that the content of glycyrrhizinic acid, which causes an unpleasant strong sweetness, was even higher.
Claims (3)
前記清心蓮子飲エキス中、グリチルリチン酸の含有量が0.22~1重量%、且つグリチルリチン酸100重量部に対するオノニンの含有量が8.34~23重量部である、漢方製剤。 A herbal medicine containing Seishinrenshiin extract,
The Chinese herbal medicine, wherein the content of glycyrrhizic acid in the Seishinrenshi-in extract is 0.22-1% by weight, and the content of ononin is 8.34-23 parts by weight per 100 parts by weight of glycyrrhizic acid.
前記清心蓮子飲エキス中、グリチルリチン酸100重量部に対しオノニンの含有量が8.34~23重量部となるように調整する、方法。
A method for suppressing the sweetness of glycyrrhizinic acid in a herbal medicine containing Seishinrenshi-in extract containing 0.22 to 1% by weight of glycyrrhizinic acid, comprising:
The method comprises adjusting the content of ononin in the Seishinrenshi-in extract to 8.34 to 23 parts by weight per 100 parts by weight of glycyrrhizinic acid.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2020110245A JP7690265B2 (en) | 2020-06-26 | 2020-06-26 | Chinese herbal medicine |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2020110245A JP7690265B2 (en) | 2020-06-26 | 2020-06-26 | Chinese herbal medicine |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022007332A JP2022007332A (en) | 2022-01-13 |
| JP7690265B2 true JP7690265B2 (en) | 2025-06-10 |
Family
ID=80111122
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020110245A Active JP7690265B2 (en) | 2020-06-26 | 2020-06-26 | Chinese herbal medicine |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP7690265B2 (en) |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2018530326A (en) | 2015-10-02 | 2018-10-18 | ザ コカ・コーラ カンパニーThe Coca‐Cola Company | Steviol glycoside sweetener with improved flavor profile |
-
2020
- 2020-06-26 JP JP2020110245A patent/JP7690265B2/en active Active
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2018530326A (en) | 2015-10-02 | 2018-10-18 | ザ コカ・コーラ カンパニーThe Coca‐Cola Company | Steviol glycoside sweetener with improved flavor profile |
Non-Patent Citations (4)
| Title |
|---|
| アグリバイオ,2018年01月20日,vol. 2, no. 1,pp. 48-53 |
| 生薬学雑誌,vol. 44, no. 3,1990年,pp. 202-206 |
| 生薬学雑誌,vol. 45, no. 3,1991年,pp. 220-226 |
| 薬学雑誌,vol. 123, no. 8,2003年,pp. 619-631 |
Also Published As
| Publication number | Publication date |
|---|---|
| JP2022007332A (en) | 2022-01-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR100934955B1 (en) | Pharmaceutical compositions and methods of using the same | |
| JP5328656B2 (en) | Cinnamomi and poria compositions and uses thereof | |
| Mills et al. | Herbal medicines in pregnancy and lactation: an evidence-based approach | |
| JP4125367B2 (en) | Chinese herbal extract | |
| WO2014094632A1 (en) | Pharmaceutical composition for treating headache, and preparation method thereof | |
| CN102228506A (en) | Composition of malaytea scurfpea extract as well as preparation method and use thereof | |
| Zhang et al. | Botany, traditional uses, phytochemistry, pharmacological and toxicological effects of Croton tiglium Linn.: a comprehensive review | |
| CN101569712B (en) | A kind of traditional Chinese medicine composition for treating cold and wind-cold | |
| JP7690265B2 (en) | Chinese herbal medicine | |
| CN102552806B (en) | Fat-burning dredging particles and preparation method thereof | |
| CN101912594A (en) | Traditional Chinese medicine preparation for treating gastrointestinal diseases | |
| JP2024092065A (en) | Lipid excretion promoter | |
| JP7545242B2 (en) | Skin roughness improver | |
| Anatolyevna et al. | Method of obtaining of extract by the method of Modified Maceration | |
| Keramatian et al. | Licorice Compound Traditional Syrup: Formulation and Development of Analysis Method | |
| JPS58172320A (en) | Antihyperlipidemic agent and its manufacturing method | |
| Sahoo et al. | Development and evaluation of Talisapatradi and Vyoshadi choorna lozenges: An ayurvedic traditional formulation | |
| CN116942779B (en) | Traditional Chinese medicine composition for treating functional dyspepsia and preparation method and application thereof | |
| CN112057536B (en) | Traditional Chinese medicine composition for preventing or/and treating dyslipidemia and application thereof | |
| CN116139238B (en) | Pharmaceutical composition and preparation method thereof | |
| JP2713549B2 (en) | Moisture-proof Chinese herbal preparation | |
| CN100496591C (en) | Medicinal preparation for freating chololithiasis and its preparation method | |
| JP2025004594A (en) | Urinary flow enhancers | |
| JP7699432B2 (en) | Appetite regulating hormone secretion normalizer | |
| JP7587929B2 (en) | Cheilitis relief agent |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20230529 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20240618 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20240806 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20241112 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20250107 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20250311 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20250507 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20250529 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 7690265 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |